Related Experiment Video
Updated: Sep 7, 2025
07:58
Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
Published on: February 25, 2014
28.8K
Ganoderic acid A improves osteoarthritis by regulating RANKL/OPG ratio
Wenxiao Wu1, Kun Song1, Guangdong Chen1
1The Third Department of Orthopaedics, Cangzhou Central Hospital, Cangzhou, China.
Chemical Biology & Drug Design
|June 16, 2022
Summary
Ganoderic acid A (GAA), derived from Ganoderma mushrooms, shows potential for treating osteoarthritis (OA). This natural compound alleviates OA pathology by regulating key molecular pathways, offering a novel therapeutic approach for joint disease.
Area of Science:
- Natural Product Chemistry
- Rheumatology
- Osteoarthritis Research
Background:
- Ganoderma mushrooms have a history of use in treating rheumatoid arthritis (RA).
- Osteoarthritis (OA) is a degenerative joint disease with limited treatment options.
- Ganoderic acid A (GAA) is a key compound extracted from Ganoderma species.
Purpose of the Study:
- To investigate the efficacy of Ganoderic acid A (GAA) in alleviating osteoarthritis (OA).
- To explore the molecular mechanisms underlying GAA's effects on OA pathology in vivo and in vitro.
Main Methods:
- A destabilization of the medial meniscus (DMM) mouse model was employed to simulate OA progression.
- Histological scoring was used to assess joint damage in the DMM model.
- The expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) was analyzed in cartilage and chondrocytes.
- Matrix metallopeptidase 13 (MMP-13) secretion was measured in synovial fluid.
- Serum OPG levels were correlated with OA severity.
Main Results:
- GAA significantly alleviated the pathological features of OA in the DMM model, indicated by reduced histologic scores.
- GAA downregulated OPG expression and upregulated RANKL expression in DMM cartilage and human articular chondrocytes (HC-A).
- GAA diminished the secretion of MMP-13 in synovial fluid.
- Serum OPG concentration was found to correlate with the severity of osteoarthritis.
Conclusions:
- Ganoderic acid A (GAA) demonstrates a therapeutic potential for osteoarthritis (OA).
- GAA improves OA by modulating the RANKL/OPG ratio, which subsequently inhibits MMP-13 secretion.
- These findings suggest GAA as a promising natural compound for OA management.
